Any discussion of BPC-157 is education-only and focused on oral supplement options
Soon after WADA took action, the FDA added BPC-157 to the so-called Category 2 Bulk Substance List, which designates it as not eligible for compounding for human use
For subcutaneous versus intramuscular research dosing considerations, see our breakdown on subcutaneous and intramuscular peptide injection, which covers needle gauge and depth recommendations relevant to reconstituted peptide delivery
At some point, this will catch up to the manager because the company will have excess or obsolete inventory in future months
If User is not agreeable to any of the terms contained herein, User shall not use, patronize, or shop on the Website
Your doctor may arrange investigations including a full blood count, serum folate levels, and in some cases, anti-intrinsic factor antibodies if pernicious anaemia hasn't been previously confirmed